Concepedia

Author

Kjeld Hermansen

Aarhus University HospitalORCID

Also Known As

A. D. Lajoix, E. Pedersen, Hermansen, K, Hermansen, Kjeld, K HERMANSEN, K Hermansen, K. HERMANSEN, K. Hermansen, KJELD HERMANSEN, Kjeld Hermansen

404

Publications

19.6K

Citations

65

H-Index

132

Concepts

All Affiliations

Aarhus University HospitalAarhus MunicipalityAarhus UniversityUniversity of CopenhagenUniversity of Eastern Finland
KH

About

Kjeld Hermansen is an author at Aarhus University Hospital specializing in medicine, diabetes, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

47

118

9.5K

2

Health Sciences

35

69

5.4K

3

Public Health

13

14

1.2K

4

Natural Sciences

5

5

357

5

Engineering

1

1

39

Kjeld Hermansen

×

218

Publications

16.4K

Citations

60

H-Index

YearCitations

Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study

B. Vessby, M Uusitupa, Kjeld Hermansen,

Diabetologia

2001

1.1K

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck, Anders Frid, Kjeld Hermansen,

Diabetes Care

2008

1.1K

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka,

The Lancet

2017

813

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

Kjeld Hermansen, Melanie J. Davies, Tadeusz Dereziński,

Diabetes Care

2006

629

Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus

J I Mann, I. De Leeuw, Kjeld Hermansen,

Nutrition Metabolism and Cardiovascular Diseases

2004

523

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

Kjeld Hermansen, Mark Kipnes, Edmund Luo,

Diabetes Obesity and Metabolism

2007

522

Antihyperglycemic effects of stevioside in type 2 diabetic subjects

Søren Gregersen, Per Bendix Jeppesen, Jens J. Holst,

Metabolism

2003

375

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

Kjeld Hermansen, P. Fontaine, K Kukolja,

Diabetologia

2004

370

Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects

Claus Thomsen, Ole Rasmussen, Thea Lousen,

American Journal of Clinical Nutrition

1999

320

Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Johan Jendle, Michael A. Nauck, David R. Matthews,

Diabetes Obesity and Metabolism

2009

295

Page 1